<DOC>
	<DOC>NCT00208936</DOC>
	<brief_summary>This study is designed pre-operative for patients with resectable, local-regional carcinoma of the esophagus.</brief_summary>
	<brief_title>Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus</brief_title>
	<detailed_description>This study is designed for patients with resectable, local-regional carcinoma of the esophagus. In a pre-operative setting, chemotherapy with Taxol, Cisplatin, and 5-Fluorouracil will be administered followed by G-CSF.</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Esophageal Diseases</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Measurable disease with resectable localregional carcinoma of the esophagus. 18 years of age or older. Pregnant or lactating. Nonresectable localregional carcinoma of the esophagus.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Esophageal Diseases</keyword>
</DOC>